Victory Capital Management
ALBO

Victory Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Victory Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22,380
Closed -$444K – 2819
2022
Q2 		$444K Buy
+22,380
New +$590K ﹤0.01% 2112
2021
Q3 		– Sell
-32,270
Closed -$1.14M – 2873
2021
Q2 		$1.14M Sell
32,270
-2,000
-6% -$65K ﹤0.01% 1846
2021
Q1 		$1.21M Sell
34,270
-1,590
-4% -$58.7K ﹤0.01% 1835
2020
Q4 		$1.34M Sell
35,860
-6,290
-15% -$229K ﹤0.01% 1655
2020
Q3 		$1.41M Sell
42,150
-4,420
-9% -$129K ﹤0.01% 1565
2020
Q2 		$1.23M Sell
46,570
-250,106
-84% -$5.9M ﹤0.01% 1630
2020
Q1 		$4.86M Buy
296,676
+144,726
+95% +$3.18M ﹤0.01% 1277
2019
Q4 		$3.86M Sell
151,950
-24,828
-14% -$497K ﹤0.01% 1278
2019
Q3 		$3.54M Buy
176,778
+117,178
+197% +$3.03M ﹤0.01% 1276
2019
Q2 		$1.92M Sell
59,600
-3,810
-6% -$127K ﹤0.01% 1150
2019
Q1 		$2.04M Sell
63,410
-8,780
-12% -$236K ﹤0.01% 1081
2018
Q4 		$1.77M Buy
72,190
+20,740
+40% +$548K ﹤0.01% 1064
2018
Q3 		$1.7M Sell
51,450
-2,820
-5% -$92.2K ﹤0.01% 1131
2018
Q2 		$1.93M Sell
54,270
-3,110
-5% -$101K ﹤0.01% 1086
2018
Q1 		$1.87M Buy
+57,380
New +$1.93M ﹤0.01% 1086

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Victory Capital Management's ALBO Position: Q3 2022 in Review

Victory Capital Management sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 22,380 shares — an estimated $444K sold.

Victory Capital Management first reported a position in ALBO in Q1 2018 and held it in 15 quarters. The position peaked at $4.86M in Q1 2020. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • Victory Capital Management reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 22,380 Albireo Pharma Inc shares in Q3 2022, an estimated $444K.
  • Victory Capital Management first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 15 quarters.
  • Victory Capital Management's Albireo Pharma Inc position peaked at $4.86M in Q1 2020.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.